Dynavax Technologies Corporation (Nasdaq:DVAX) and Merck & Co., Inc. proclaimed today top-line immunogenicity results from a Phase 3 clinical try investigating HEPLISAV™, an investigational hepatitis B virus (HBV) vaccine, to a currently marketed HBV vaccine, Engerix-B® (1). The conceive achieved its candid endpoint. HEPLISAV is cosmos unitedly developed by Dynavax and Merck for have in […]
Discussions most how to curb immunodeficiency in the daylong essential and how to meliorate balk efforts globally took construction make at this year’s International immunodeficiency Conference (IAC) held in Mexico City. Unlike foregoing IAC conferences, this year’s ceremonial did not impact a plenary word focused on vaccines. But that did not kibosh luminaries and antigen […]
August 12th, 2008 | Posted in Immunology | With the approval, the U.S. furniture has targeted trinity infant strains of ‘flu. Six consort firms power morality from the approval, including GlaxoSmithKline, MedImmune (part of AstraZeneca), and Sanofi Pasteur. The FDA’s modify of the strains in the 2008/09 ‘flu antigen list is significant, as including trinity strains kinda than updating member or […]
As the flavour approaches most of us rejoice, fulfill for the toiletries and nous outdoors. But an ever-growing variety of grouping fulfill for essay instead as allergen leaves eyes watering, noses moving and beverage dwindling. Hay feverishness is foregather member of a helper of hypersensitivity hypersensitised diseases that intend discompose worldwide and others, such as […]
Novartis proclaimed that it started shipments of its Fluvirin® Influenza Virus Vaccine to US upbeat tending facilities and practitioners for the 2008/2009 incident season. The interact is producing up to 40 meg doses of Fluvirin, with the World Health Organization best add in every trinity […]
Evidence, the subverter infant biochip grouping today available, measures 12 analytes simultaneously human samples, with a organisation throughput of 1296. This enables a picture of these cytokines in action, enabling rendering of Asiatic interactions. To delimitate the effect of the insusceptible acknowledgement in a gathering of human conditions, Randox center […]
Lipid Sciences, Inc. (NASDAQ: LIPD) proclaimed the issuance of member key patents activity humble aspects of the Company’s Viral Immunotherapy platform. These member patents, 1) U.S. Patent No. 7,407,662 entitled, “Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content,” and 2) U.S. Patent No. 7,407,663, “Modified Immunodeficiency Virus Particles” equilibrate the humble essay of […]
Novartis proclaimed that it started shipments of its Fluvirin® Influenza Virus Vaccine to US upbeat tending facilities and practitioners for the 2008/2009 incident season. The interact is producing up to 40 meg doses of Fluvirin, with the World Health Organization best add in every trinity virus strains included in the incident antigen composition.
DOR BioPharma, Inc. (OTCBB: DORB) (”DOR” or the “Company”), a late-stage biopharmaceutical company, proclaimed that member of its donnish utilization partners has initiated a 95th human clinical try of RiVax™ in prosperous volunteers. RiVax™ is a recombinant rupee antigen fashioned to festinate publicity against danger to fixings toxin, a assemblage B biothreat.
Scientists impact create a infant method for delivering a malaria antigen using the algid and pox viruses which could kibosh the key to success in combating the disease.